psoriasis

Johnson & Johnson (JNJ) reports Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis
Marketscreener
Fri, 05/9/25 - 08:59 am
JNJ
clinical trials
icotrokinra
psoriasis
FDA puts Vyne in a twist, slapping hold on psoriasis trial over testicular toxicity concerns
Fierce Biotech
Fri, 04/25/25 - 11:17 am
Vyne Therapeutics
FDA
psoriasis
clinical trials
J&J shows its confidence in oral IL-23 drug for psoriasis
Pharmaphorum
Mon, 03/10/25 - 09:25 am
JNJ
icotrokinra
psoriasis
Stelara
clinical trials
Johnson and Johnson Submits FDA Request for Pediatric Tremfya Approval
Managed Healthcare Executive
Mon, 12/2/24 - 07:17 pm
JNJ
Tremfya
pediatric
psoriasis
juvenile psoriatic arthritis
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Clinical Trials Arena
Tue, 11/19/24 - 11:00 am
JNJ
clinical trials
JNJ-2113
psoriasis
BMS reports four-year data from psoriasis treatment extension trial
Clinical Trials Arena
Fri, 05/17/24 - 11:14 am
Bristol Myers Squibb
Sotyktu
clinical trials
psoriasis
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena
Wed, 05/8/24 - 11:01 pm
LEO Pharma
clinical trials
psoriasis
Enstilar
Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS
Pharma Voice
Wed, 03/27/24 - 10:56 am
Takeda
cliincal trials
TAK-279
Bristol Myers Squibb
clinical trial diversity
psoriasis
J&J Gets Phase II Win for First Targeted Oral Peptide in Plaque Psoriasis
BioSpace
Mon, 03/11/24 - 12:00 pm
JNJ
clinical trials
JNJ-2113
psoriasis
UCB launches DTC Bimzelx ad blitz at the Oscars
Medical Marketing and Media
Sun, 03/10/24 - 08:23 pm
UCB Pharma
DTC advertising
Oscars
psoriasis
Eli Lilly Has More Than an Ozempic Competitor -- Much More
Motley Fool
Wed, 02/21/24 - 11:14 am
Eli Lilly
obesity
cancer
diabetes
psoriasis
Alzheimer's disease
Johnson & Johnson reports data from Phase II plaque psoriasis trial
Clinical Trials Arena
Thu, 02/8/24 - 11:14 am
JNJ
clinical trials
psoriasis
JNJ-2113
Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake
Fierce Pharma
Tue, 11/28/23 - 11:29 pm
Dermavant
Vtama
psoriasis
Botox
Even with phase 2 success, Ventyx halts TYK2 inhibitor, sending stock plummeting 70%
Fierce Biotech
Tue, 11/7/23 - 10:00 am
Ventyx Biosciences
clinical trials
TYK2 inhibitors
VTX958
psoriasis
Janssen tackles racial gap in Phase IIIb psoriasis trial with Tremfya
Clinical Trials Arena
Fri, 10/20/23 - 11:39 am
Janssen
psoriasis
Tremfya
clinical trials
UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks
BioSpace
Thu, 10/19/23 - 10:15 am
UCB
bimekizumab
psoriasis
FDA
Bimzelx
Beaten by placebo, Evelo seeks partner for once-lauded microbiome platform and programs
Fierce Biotech
Tue, 10/17/23 - 09:57 pm
Evelo Biosciences
microbiome
clinical trials
psoriasis
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
AbbVie
Skyrizi
Amgen
Otezla
Boehringer Ingelheim
psoriasis
BMS’ Sotyktu cleared for NHS use in psoriasis
Pharmaphorum
Thu, 06/29/23 - 11:33 am
Bristol Myers Squibb
Sotyktu
psoriasis
NHS
UK
Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Clinical Trials Arena
Thu, 05/25/23 - 12:48 pm
JNJ
Janssen
Tremfya
psoriasis
real world data

Pages